Nephros Inc. Files 8-K for Operations and Financials
Ticker: NEPH · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1196298
| Field | Detail |
|---|---|
| Company | Nephros Inc (NEPH) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations, sec-filing
TL;DR
Nephros filed an 8-K on March 7th for financial and operational updates.
AI Summary
Nephros, Inc. filed an 8-K on March 7, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing serves as an official update on Nephros, Inc.'s financial health and operational performance, which is crucial information for investors and stakeholders.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial and operational information, not indicating any immediate adverse events.
Key Players & Entities
- Nephros, Inc. (company) — Registrant
- March 7, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-32288 (identifier) — Commission File Number
- 13-3971809 (identifier) — IRS Employer Identification No.
- 380 Lackawanna Place, South Orange, New Jersey 07079 (address) — Principal executive offices
- (201) 343-5202 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported in this 8-K?
The provided text of the 8-K filing does not contain specific financial results; it only indicates that the filing pertains to 'Results of Operations and Financial Condition'.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is March 7, 2024.
What is the Commission File Number for Nephros, Inc.?
The Commission File Number for Nephros, Inc. is 001-32288.
Where are Nephros, Inc.'s principal executive offices located?
Nephros, Inc.'s principal executive offices are located at 380 Lackawanna Place, South Orange, New Jersey 07079.
What are the main items covered by this 8-K filing?
This 8-K filing covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
Filing Stats: 523 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-03-07 16:15:21
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value NEPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 115KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-009216.txt ( ) — 337KB
- neph-20240307.xsd (EX-101.SCH) — 3KB
- neph-20240307_lab.xml (EX-101.LAB) — 33KB
- neph-20240307_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Nephros, Inc. Dated: March 7, 2024 By: /s/ Judy Krandel Judy Krandel Chief Financial Officer